Time-varying association of first-line bevacizumab with progression-free survival in advanced ovarian cancer: A multicenter matched cohort study.
- DOI
- 10.17305/bb.2026.14858
- Published
- 2026 Oct 26
- Container
- Biomolecules & biomedicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.17305/bb.2026.14858,
title = {Time-varying association of first-line bevacizumab with progression-free survival in advanced ovarian cancer: A multicenter matched cohort study.},
author = {Katić K and Čerina Pavlinović D and Canjko I and Majić A and Jakšić B and Vujić G and Fröbe A and Bajić Ž and Milković Periša M and Vrdoljak E},
year = {2026},
journal = {Biomolecules \& biomedicine},
doi = {10.17305/bb.2026.14858},
url = {https://doi.org/10.17305/bb.2026.14858}
}RIS
TY - JOUR TI - Time-varying association of first-line bevacizumab with progression-free survival in advanced ovarian cancer: A multicenter matched cohort study. AU - Katić K AU - Čerina Pavlinović D AU - Canjko I AU - Majić A AU - Jakšić B AU - Vujić G AU - Fröbe A AU - Bajić Ž AU - Milković Periša M AU - Vrdoljak E PY - 2026 JO - Biomolecules & biomedicine DO - 10.17305/bb.2026.14858 UR - https://doi.org/10.17305/bb.2026.14858 ER -
APA
K, K., D, Č. P., I, C., A, M., B, J., G, V., A, F., Ž, B., M, M. P., & E, V. (2026). Time-varying association of first-line bevacizumab with progression-free survival in advanced ovarian cancer: A multicenter matched cohort study.. Biomolecules & biomedicine. https://doi.org/10.17305/bb.2026.14858
Source records
- pubmed · retrieved 2026-11-10T08:33:46.373Z